Studies on antibody formation in patients treated with L-asparaginase.
D000208:Acute Disease; D000328:Adult; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D001215:Asparaginase / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D001853:Bone Marrow / Q000378:metabolism; D001854:Bone Marrow Cells; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology; D007073:Immunoglobulin E / Q000032:analysis; D007456:Iodine Isotopes; D007938:Leukemia / Q000188:drug therapy / Q000201:enzymology / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011863:Radioimmunoassay; D014316:Tritium; D014633:Valine / Q000378:metabolism
D000906:Antibodies; D007456:Iodine Isotopes; D014316:Tritium; D007073:Immunoglobulin E; D001215:Asparaginase; D014633:Valine